Cryptococcosis in patients with cirrhosis of the liver and posttransplant outcomes

Transplantation

Volumn 99, Issue 10, 2015, Pages 2132-2141

  Singh, Nina ^a   Sifri, Costi D ^b   Silveira, Fernanda P ^a   Miller, Rachel ^c   Gregg, Kevin S ^d   Huprikar, Shirish ^e   Lease, Erika D ^f   Zimmer, Andrea ^g   Stephen Dummer, J ^g   Spak, Cedric W ^h   Koval, Christine ⁱ   Banach, David B ^j   Shroff, Miloni ^k   Le, Jade ^k   Ostrander, Darin ^l   Avery, Robin ^l   Eid, Albert ^m   Razonable, Raymund R ⁿ   Montero, Jose ^o   Blumberg, Emily ^p   Alynbiawi, Ahlaam ^q   Morris, Michele I ^q   Randall, Henry B ^r   Alangaden, George ^s   Tessier, Jeffrey ^t   Wagener, Marilyn M ^a   Sun, Hsin Yun ^u   more..

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g VANDERBILT UNIVERSITY   (United States)

^h Baylor Hospital   (United States)

ⁱ LERNER RESEARCH INSTITUTE   (United States)

^j YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^l JOHNS HOPKINS UNIVERSITY   (United States)

^m UNIVERSITY OF KANSAS   (United States)

ⁿ MAYO CLINIC   (United States)

^o UNIVERSITY OF SOUTH FLORIDA   (United States)

^p UNIVERSITY OF PENNSYLVANIA   (United States)

^q UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^r ST LUKE S HOSPITAL   (United States)

^s HENRY FORD HOSPITAL   (United States)

^t VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^u NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE;

ADULT; ARTICLE; CRYPTOCOCCOSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; FUNGEMIA; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT PLANNING; CLINICAL TRIAL; COMPLICATION; GRAFT RECIPIENT; LIVER; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PROGNOSIS;

ANTIFUNGAL AGENTS; CRYPTOCOCCOSIS; DISEASE PROGRESSION; FEMALE; FLUCONAZOLE; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; TRANSPLANT RECIPIENTS; TREATMENT OUTCOME;

EID: 84943139097     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000690     Document Type: Article

References (21)

1. Chuang YM, Ho YC, Chang HT, Yu CJ, Yang PC, Hsueh PR. Disseminated cryptococcosis in HIV-uninfected patients. Eur J Clin Microbiol Infect Dis. 2008;27(4):307-310.
2. Hwang SY, Yu SJ, Lee JH, et al. Spontaneous fungal peritonitis: a severe complication in patients with advanced liver cirrhosis. Eur J Clin Microbiol Infect Dis. 2014;33(2):259-264.
3. Singh DK, Tyagi I, Saran RK, Gondal R. Fatal spontaneous Cryptococcal peritonitis in a woman with decompensated liver cirrhosis. Acta Cytol. 2010;54(5 Suppl):1087-1089.
4. Singh N, Husain S, De Vera M, Gayowaski T, Cacciarelli TV. Cryptococcus neoformans infection in patients with cirrhosis, including liver transplant candidates. Medicine. 2004;83:188-192.
5. Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2010;50(3):291-322.
6. Jean SS, Fang CT, Shau WY, et al. Cryptococcaemia: clinical features and prognostic factors. QJM. 2002;95:511-518.
7. Sifri CD, Sun HY, Cacciarelli TV, Wispelwey B, Pruett TL, Singh N. Pretransplant cryptococcosis and outcome after liver transplantation. Liver Transpl. 2010;16(4):499-502.
8. Sun HY, Alexander BD, Lortholary O, et al. Unrecognized pretransplant and donor-derived cryptococcal disease in organ transplant recipients. Clin Infect Dis. 2010;51(9):1062-1069.
9. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46(12): 1813-1821.
10. Singh N, Perfect JR. Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect Dis. 2007;7:395-401.
11. Pappas PG, Perfect JR, Cloud GA, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis. 2001;33:690-699.
12. Dismukes WE, Cloud G, Gallis HA, Kerkering TM, Mwsodd F, Craven PCea. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med. 1987;317:334-341.
13. Diamond RD, Bennett JE. Prognostic factors in cryptococcal meningitis: a study in 111 cases. Ann Intern Med. 1974;80:176-181.
14. Sun HY, Singh N. Opportunistic infection-associated immune reconstitution syndrome in transplant recipients. Clin Infect Dis. 2011;53(2):168-176.
15. Massarollo PC, Mies S, Abdala E, Leitao RMRS. Immunosuppression withdrawal for treatment of severe infections in liver transplantation. Transplant Proc. 1998;4:1472-1474.
16. Vecchiarelli A, Retini C, Monari C, Tascini C, Bistoni F, Kozel TR. Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. Infect Immun. 1996;64:2846-2849.
17. Concejero AM, Yong CC, Chen CL, et al. Solitary pulmonary nodule in the liver transplant candidate: importance of diagnosis and treatment. Liver Transpl. 2010;16(6):760-766.
18. Mills SA, Seigler HF, Wolfe WG. The incidence and management of pulmonary mycosis in renal allograft patients. Ann Surg. 1975;182(5): 617-626.
19. Swenson RS, Kountz SL, Blank N, Merigan TC. Successful renal allograft in a patient with pulmonary cryptococcus. Arch Intern Med. 1969;124(4): 502-506.
20. Silveira FP, Husain S, Kwak EJ, et al. Cryptococcosis in liver and kidney transplant recipients receiving anti-thymocyte globulin or alemtuzumab. Transpl Infect Dis. 2007;9(1):22-27.
21. Kontoyiannis DP, Lewis RE, Alexander BD, et al. Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates; Correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother. 2008;52:735-738.